MHC-derived peptides and the CD4+ T-cell repertoire: Implications for autoimmune disease

Cytokines, Cellular and Molecular Therapy

Volumn 3, Issue 2, 1997, Pages 115-125

  Baum, Harold ^a   Staines, Norman A ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Antigenic mimicry; Autoimmune disease; MHC derived peptides; Molecular mimicry; Susceptibility allele; T cell selection

Indexed keywords

CD4 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PEPTIDE; T LYMPHOCYTE ANTIGEN; T LYMPHOCYTE RECEPTOR;

ALLELE; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CHAGAS DISEASE; CROSS REACTION; DATA BASE; DIABETES MELLITUS; DISEASE PREDISPOSITION; ETIOLOGY; HAPLOTYPE; HUMAN; HUMAN CELL; LEPROSY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR MIMICRY; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; THYMUS; UVEITIS;

ALLELES; AMINO ACID SEQUENCE; ANIMALS; ARTHRITIS, RHEUMATOID; AUTOANTIGENS; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CHAGAS DISEASE; DIABETES MELLITUS, TYPE 1; HISTOCOMPATIBILITY ANTIGENS; HUMANS; IMMUNODOMINANT EPITOPES; LEPROSY; LIVER CIRRHOSIS, BILIARY; MAJOR HISTOCOMPATIBILITY COMPLEX; MODELS, BIOLOGICAL; MOLECULAR MIMICRY; MOLECULAR SEQUENCE DATA; UVEITIS;

EID: 0030815664     PISSN: 13684736     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. Ferrick DA, Ohashi PS, Wallace V et al, Thymic ontogeny and selection of αβ and γδ T cells. Immunol Today (1989) 10: 403-7.
2. Ahston-Rickardt PG, Tonegawa S, A differential-avidity model for T-cell selection. Immunol Today (1994) 15: 362-6.
3. Chicz RM, Urban RG, Lane WS et al, Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are hetero-geneous in size. Nature (1992) 358: 764-8.
4. Romagnoli P, Germain RN, The CLIP region of invariant chain plays a critical role in regulating major histocompatibility complex class II folding, transport and peptide occupancy. J Exp Med (1994) 180: 1107-13.
5. Cohen IR, Kadishman's tree, Escher's angels, and the immunological homunculus. Isr J Med Sci (1996) 32: 44-50.
6. Rider BJ, Fraga E, Yu Q, Singh B, Immune responses to self peptides naturally presented by murine class II major histocompatibility complex molecules. Mol Immunol (1996) 33: 625-33.
7. Colovai AI, Liu Z, Harris PE et al, Allopeptide-specific T cell reactivity altered by peptide analogs. J Immunol (1997) 158: 48-54.
8. Adorini L, Appella E, Doria G, Nagy ZA, Mechanisms influencing the immunodominance of T-cell determinants. J Exp Med (1988) 168: 2091-104.
9. Lanzavechhia A, Antigen-specific interaction between T and B cells. Nature (1985) 314: 537-9.
10. Simitsek PD, Campbell DG, Lanzavechhia A et al, Modulation of antigen processing by bound antibodies can boost or suppress class II major histocompatibility complex presentation of T-cell determinants. J Exp Med (1995) 181: 1957-63.
11. Muller CP, Handtmann D, Brons NHC et al, Analysis of antibody responses to the measles virus using synthetic peptides of the fusion protein. Evidence of non-random pairing of T and B cell epitopes. Virus Res (1993) 30: 271-80.
12. Olmos P, Ahern R, Heaton DA et al, The significance of the concordance rate for Type 1 (insulin-dependent) diabetes in identical twins. Diabetologia (1988) 31: 747-50.
13. Taurog JD, Richardson JA, Croft JT et al, The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med (1994) 188: 2359-64.
14. Oldstone MBA, Molecular mimicry as a mechanism for the cause and as a probe uncovering etiologic agent(s) of autoimmune disease. Curr Top Microbial Immunol (1989) 145: 127-35.
15. Hall R, Molecular mimicry. Adv Parasitol (1994) 34: 81-133.
16. Oldstone MBA, Molecular mimicry and autoimmune disease. Cell (1987) 50: 819-20.
17. Froude J, Gibofsky J, Buskirk DR et al, Rheumatic fever. Curr Top Microbial Immunol (1989) 145: 5-26.
18. Wucherpfennig KW, Strominger JL, Molecular mimicry in T-cell mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell (1995) 80: 695-705.
19. von Herrath MG, Oldstone MBA, Virus-induced autoimmune disease. Curr Opin Immunol (1996) 8: 878-85.
20. Baum H, Davies H, Peakman M, Molecular mimicry in the MHC: hidden clues to autoimmunity? Immunol Today (1996) 17: 64-70.
21. She J-X, Susceptibility to type 1 diabetes: HLA-DQ and DR revisited. Immunol Today (1996). 17: 323-9.
22. Breweton DA, Hart FD, Nicholls A et al, Ankylosing spondylitis and HLA-A27. Lancet (1973) i: 904-7.
23. Winchester R, Dwyer E, Rose S, The genetic basis of rheumatoid arthritis: the shared epitope hypothesis. Rheum Dis Clin N Am (1992) 18: 761-83.
24. Quartey-Papfio R, Lund T, Chandler P et al, Aspartate at position 57 of non-obese diabetic I-A (g7) beta-chain diminishes the spontaneous incidence of insulin-dependent diabetes mellitus. J Immunol (1995) 154: 5567-75.
25. McDevitt HO, Bodmer WF, HLA, immune response genes and disease. Lancet (1974) i: 1269-75.
26. Wucherpfennig KW, Strominger JL, Selective binding of self-peptides to disease-associated major histocompatibility complex (MHC) molecules: a mechanism for MHC-linked susceptibility to human autoimmune diseases. J Exp Med (1995) 181: 1597-601.
27. Hawke S, Matsuo H, Nicolle M et al, Autoimmune T cells in myasthenia gravis: heterogeneity and potential for specific immunotargeting. Immunol Today (1996) 17: 307-11.
28. Chicz RM, Urban RG, Groga JC et al, Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J Exp Med (1993) 178: 22-47.
29. Baum H, Wilson C, Tiwana H et al, HLA association with autoimmune disease: restricted binding or T-cell selection? Lancet (1995) 346: 1042-3.
30. Baum H, Molecular mimicry with MHC-derived peptides; does this underlie MHC-association with autoimmune disease? Biochem Soc Trans (1997) in press.
31. Baum H, Butler P, Davies H et al, Autoimmune disease and molecular mimicry: an hypothesis. Trends Biochem Sci (1993) 18: 140-4.
32. Zanelli E, Krco CJ, Baisch JM et al, Immune response of HLA-DQ8 transgenic mice to peptides from the third hypervariable region of HLA-DRB1 correlates with predisposition to rheumatoid arthritis. Proc Natl Acad Sci USA (1996) 93: 1814-19.
33. Gonzalez-Gay MA, Zanelli E, Khare SD et al, Human leukocyte antigen-DRB1*1502 (DR2 Dw12) transgene reduces incidence and severity of arthritis in mice. Hum Immunol (1996) 50: 54-60.
34. Albani S, Keystone EC, Nelson JL et al, Positive selection in autoimmunity: abnormal immune responses to a bacterial dnaJ antigenic determinant in patients with early rheumatoid arthritis. Nature Med (1995) 1: 448-52.
35. Kouskoff V, Korganow A-S, Duchatelle V et al, Organ-specific disease provoked by systemic autoimmunity. Cell (1996) 87: 811-22.
36. Sanui H, Redmond TM, Kotake S et al, Identification of an immunodominant and highly immunopathogenic determinant in the retinal interphoto-receptor retinoid-binding protein (IRBP). J Exp Med (1989) 169: 1947-60.
37. Wildner G, Thurau SR, Cross-reactivity between an HLA-B27-derived peptide and a retinal autoantigen peptide: a clue to major histocompatibility complex association with autoimmune disease. Eur J Immunol (1994) 24: 2579-85.
38. + cells suppress experimental autoimmune uveitus. Eur J Immunol (1996) 26: 2140-8.
39. Kaplan MM, Medical progress: primary biliary cirrhosis. N Engl J Med (1987) 316: 521-8.
40. Baum H, Mitochondrial antigens, molecular mimicry and autoimmune disease. Biochem Biophys Acta (1995) 1271: 111-21.
41. Lindenborn-Fotinos J, Baum H, Berg PA, Mitochondrial antibodies in primary biliary cirrhosis: species and nonspecies specific determinants of M2 antigen. Hepatology (1985) 5: 763-9.
42. Butler P, Hamilton-Miller JMT, Baum H, Burroughs AK, Detection of M2 antibodies in patients with recurrent urinary tract infection using an ELISA and purified PBC specific antigens. Biochem Mol Biol Intl (1995) 35: 473-85.
43. Burroughs AK, Butler P, Sternberg MJE, Baum H, Molecular mimicry and liver disease. Nature (1992) 358: 377-8.
44. Shimoda S, Nakamura M, Ishibashi H et al, HLA DRB4 0101-restricted immunodominant T cell autopeptide of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases. J Exp Med (1995) 181: 1835-45.
45. Szostecki C, Guldner HH, Netter HJ, Wull H, Isolation and characterization of cDNA encoding a human nuclear antigen predominantly recognised by auto antibodies from patients with primary biliary cirrhosis. J Immunol (1990) 145: 4338-47.
46. Tartakovsky F, Worman HJ, Detection of gp210 autoantibodies in primary biliary cirrhosis using a recombinant protein containing the predominant autoepitope. Hepatology (1995) 21: 495-500.
47. Apt W, Aguilera X, Arribada A et al, Epidemiology of Chagas' disease in northern Chile: isozyme profiles of Trypanosoma cruzi from domestic and sylvatic transmission cycles and their association with cardiopathy. Am J Trop Med Hyg (1987) 37: 302-7.
48. Cunha-Neto E, Duranti M, Gruber A et al, Autoimmunity in Chagas' disease cardiopathy: biological relevance of a cardiac myosin-specific epitope crossreactive to an immunodominant Trypanosoma cruzi antigen. Proc Natl Acad Sci USA (1995) 92: 3541-5.
49. +ATPase: a possible mechanism for the autoimmune pathology of Chagas' disease. In: Abstr 9th Intl Congr Immunol (1995) Abstr 3286.
50. Baum H, Gramaglia I, Colston MJ, Molecular mimicry with HLA-gamma invariant chain as a possible mechanisms of autoimmune pathology in leprosy. In: Abstr 9th Intl Congr Immunol (1995) Abstr 4846.
51. Kataoka S, Satoh J, Fujiya H et al, Immunologic aspects of the nonobese diabetic (NOD) mouse. Abnormalities of cellular immunity. Diabetes (1983) 32: 247-53.
52. Kaufman DL, Clare-Salzler M, Tian J et al, Spontaneous loss of T-cell tolerance to glutamic acid decraboxylase in murine insulin-dependent diabetes. Nature (1993) 366: 69-72.
53. Baum H, Cunningham P, Do MHC antigens generate pathogenetic peptides? Immunol Today (1994) 15: 388-9.
54. Hanson MS, Cetkovic-Cvrlje M, Ramiya VK et al, Quantitative thresholds of MHC Class II I-E expressed on hemopoietically derived antigen-presenting cells in transgenic NOD/Lt mice determine level of diabetes resistance and indicate mechanism of protection. J Immunol (1996) 157: 1279-87.
55. Shehadeh N, Calcinaro F, Bradley BJ et al, Effect of adjuvant therapy on development of diabetes in mouse and man. Lancet (1994) 343: 706-7.
56. Gearson CL, Stevens EJ, Vergani D et al, Mimicry between glutamic acid decarboxylase and MHC class II molecules as a mechanism of autoimmuine diabetes. Autoimmunity (1996) 24(Suppl 1): 32.
57. + T-cell clones in vivo. Diabetes (1996) 45: 1121-31.
58. Baum H, Brusic V, Choudhuri K et al, MHC molecular mimicry in diabetes. Nature Med (1995) 1: 388.
59. Jurcevic S, Travers PJ, Hills A et al, Distinct conformations of a peptide bound to HLA-DR1 or DRB5*0101 suggested by molecular modelling. Intl Immunol (1996) 8: 1807-14.
60. Evavold BD, Sloan-Lancaster J, Wilson KJ et al, Specific T-cell recognition of minimally homologous peptides: evidence for multiple endogenous ligands. Immunity (1995) 2: 655-63.
61. Ebringer A, Ankylosing spondylitis is caused by Klebsiella: evidence from immunogenetics, microbiologic and serologic studies. Rheum Dis Clin N Am (1992) 18: 105-21.
62. Guardiola J, Maffei A, Lauster R et al, Tissue Antigens (1996) 48: 615-25.
63. Treichel U, McFarlane BM, Seki T et al, Demographics of anti-asialoglycoprotein receptor autoantibodies in autoimmune hepatitis. Gastroenterology (1994) 107: 799-804.
64. Ma Y, Peakman M, Lobo-Yeo A et al, Differences in immune recognition of cytochrome P4502D6 by liver kidney microsomal (LKM) antibody in autoimmune hepatitis and chronic hepatitis C virus infection. Clin Exp Immunol (1994) 97: 94-9.
65. Brusic V, Rudy G, Kyne AP, Harrison LC, MHCPEP - a database of MHC-binding peptides: update 1995. Nucleic Acids Res (1996) 24: 242-4.
66. Baum H, Peakman M, Norazmi MN, Vergani D, Molecular mimicry and the T-cell repertoire. Diabetologia (1996) 39: 246-7.
67. Szopa TM, Tichener PA, Portwood ND, Taylor KW, Diabetes mellitus due to viruses - some recent developments. Diabetologia (1993) 36: 687-95.
68. Norazmi MN, Peakman M, Vergani D, Baum H, Shared amino acid sequences between glutamic acid decarboxylase 65 and 67 and alpha-2-macroglobulin: a focus for cross-reactive autoantibodies? Diabetologia (1995) 38: 874-5.